Kyle Carver

Insider Reports History

Location
New York, NY
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Carver:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Chief Financial Officer Common Stock 62,510 $1,115,178 $17.84 09 Dec 2025 Direct
Evommune, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 279,408 05 Nov 2025 Direct
Evommune, Inc. Chief Financial Officer Series B Preferred Stock 0 07 Nov 2025 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Common Stock 0 $9.50 09 Nov 2021 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by Kyle Carver

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000175707225000010-carver-kyle-2025-12-09 Evommune, Inc. 09 Dec 2025 1 -$237,094 4 Chief Financial Officer 11 Dec 2025, 16:20
/report/000175707225000008-carver-kyle-2025-11-07 Evommune, Inc. 07 Nov 2025 2 $0 4 Chief Financial Officer 12 Nov 2025, 16:16
/report/000175707225000006-carver-kyle-2025-11-05 Evommune, Inc. 05 Nov 2025 1 $0 4 Chief Financial Officer 07 Nov 2025, 16:15
/report/000175707225000004-carver-kyle-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Chief Financial Officer 05 Nov 2025, 20:01
/report/000110465921136396-carver-kyle-2021-11-09 Kadmon Holdings, Inc. 09 Nov 2021 6 -$2,523,590 4 SVP, CAO, Controller 09 Nov 2021, 16:36